Beryllium-stimulated apoptosis in macrophage cell lines

Toxicology

Volumn 149, Issue 2-3, 2000, Pages 129-142

  Sawyer, Richard T ^a,b   Fadok, Valerie A ^c   Kittle, Lori A ^a   Maier, Lisa A ^a,b   Newman, Lee S ^a,b  

^a Div Environ and Occup Hlth Sci   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Apoptosis; BD fmk; Beryllium; Caspase; Chronic beryllium disease; Dendritic cell; Granulomatous disease; Macrophage; Tumor necrosis factor

Indexed keywords

ALUMINUM SULFATE; BERYLLIUM; CASPASE; CASPASE INHIBITOR; KETONE DERIVATIVE; PROPIDIUM IODIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; BERYLLIOSIS; CELL LINE; CHRONIC GRANULOMATOUS DISEASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENDRITIC CELL; DOSE TIME EFFECT RELATION; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; LUNG LAVAGE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0034699016     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(00)00237-7     Document Type: Article

References (60)

1. Ashkenazi A., Dixit V.M. Apoptosis control by death and decoy receptors. Curr. Opin. Cell Biol. 11:1999;255-260.
2. Bost T.W., Riches D.W.G., Schumacher B.A., Carre P.C., Kahn T.Z., Marteniz J.A.B., Newman L.S. Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for tumor necrosis factor-α and interleukin-6 but not interleukin-1β Am. J. Respir. Cell Mol. Biol. 10:1994;506-513.
3. Brown T.L., Patil S., Basnett R.K., Howe P.H. Caspase inhibitor BD-fmk distinguishes transforming growth factor β-induced apoptosis from growth inhibition. Cell Growth Diff. 9:1998;869-875.
4. 2+ is inhibited by a variety of structurally unrelated inhibitors. Biochem. Cell Biol. 72:1994;631-638.
5. Canono B.P., Campbell P.A. Production of mouse inflammatory macrophage hybridomas. J. Tiss. Cult. Methods. 14:1992;3-8.
6. Catelas I., Petit A., Zukor D.J., Marchand R., Yahia L.H., Huk O.L. Induction of macrophage apoptosis by ceramic and polyethylene particles in vitro. Biomaterials. 20:1999;625-630.
7. Cheng Y., Deskmukh M., D'Costa A., Demaro J.A., Gidday J.M., Shah A., Sun Y., Jacquin M.F., Johnson E.M. Jr, Holtzman D.M. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J. Clin. Invest. 101:1998;1992-1999.
8. Cohen G.M. Caspases: the executioners of apoptosis. Biochem. J. 326:1997;1-16.
9. Dai H., Guzman J., Costabel U. Increased expression of apoptosis signaling receptors by alveolar macrophages in sarcoidosis. Eur. Respir. J. 13:1999;1451-1454.
10. Deshmukh M., Vasilakos J., Deckwerth T.L., Lampe P.A., Shivers B.D., Johnson E.M. Jr. Genetic and metabolic status of NGF-deprived sympathetic neurons saved by an inhibitor of ICE family proteases. J. Cell Biol. 135:1996;1341-1345.
11. Devitt A., Moffatt O.D., Raykundalia C., Capra J.D., Simmons D.L., Gregory C.D. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature. 392:1998;505-509.
12. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 391:1998;43-50.
13. Ferris B.G. Epidemiology Standardization Project. Am. Rev. Respir. Dis. 118:1978;1-20.
14. Fireman E., Efraim S.B., Messer G., Dabush S., Greif J., Topilsky M. Cell-free supernatants of sarcoid alveolar macrophages suppress proliferation of sarcoid alveolar fibroblasts. Clin. Immunol. Immunopathol. 59:1991;368-378.
15. Fontenot A.P., Kotzin B.L., Comment C.E., Newman L.S. Expansions of T-cell subsets expressing particular T-cell receptor variable regions in chronic beryllium disease. Am. J. Respir. Cell Mol. Biol. 18:1998;581-589.
16. Fontenot A.P., Falta M.T., Newman L.S., Kotzin B.L. Identification of pathogenic T cells in patients with beryllium-induced lung disease. J. Immunol. 163:1999;1019-1026.
17. Fraker P.J., Telford W.G. A reappraisal of the role of zinc in life and death decisions of cells. Proc. Soc. Exp. Biol. Med. 215:1997;229-236.
18. Frasch S.C., Nick J.A., Fadok V.A., Bratton D.L., Worthen S.G., Henson P.M. P38 mitogen-activated protein kinase-dependent and -independent intracellular signal transduction pathways leading to apoptosis in human neutrophils. J. Biol. Chem. 273:1998;8389-8397.
19. Green D.R., Reed JC. Mitochondria and apoptosis. Science. 281:1998;1309-1312.
20. Hall J.G. Studies on the adjuvant action of beryllium. IV. The preparation of beryllium containing macromolecules that induce immunoblast responses in vivo. Immunol. 64:1988;345-351.
21. Hart B.A., Pittman D.G. The uptake of beryllium by alveolar macrophage. J. Reticuloendothel. Soc. 27:1980;49-58.
22. Hildeman D.A., Mitchell T., Teague T.K., Henson P.M., Day B.J., Kappler J., Marrack P.C. Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity. 10:1999;735-744.
23. Kittle L.A., Sawyer R.T., Fadok V.A., Maier L.A., Newman L.S. Beryllium-stimulated macrophage apoptosis. Am. J. Respir. Crit. Care Med. 161:2000;A731.
24. Kohroki J., Muto N., Tanaka T., Itoh N., Inada A., Tanaka K. Induction of differentiation and apoptosis by dithizone in human myeloid leukemia cell lines. Leukemia Res. 22:1998;405-412.
25. Kunitake R., Kuwnao K., Miyazaki H., Hagimoto N., Nomoto Y., Hara N. Apoptosis in the course of granulomatous inflammation in pulmonary sarcoidosis. Eur. Respir. J. 13:1999;1329-1337.
26. Leigh J., Wang H., Bonin A., Peters M., Ruan X. Silica-induced apoptosis in alveolar and granulomatous cells in vivo. Environ. Health Perspect. 105:(Suppl. 5):1997;1241-1245.
27. Levi-Setti R., Berry J.P., Chabala J.M., Galle P. Selective intracellular beryllium localization in rat tissue by mass-resolved ion microprobe imaging. Biol. Cell. 63:1988;77-82.
28. Lindenschmidt R.C., Sendelbach L.E., Witschi H.P., Price D.J., Fleming J., Joshi J.G. Ferritin and in vivo beryllium toxicity. Toxicol. Appl. Pharmacol. 82:1986;344-350.
29. Liu X., Zou H., Slaughter C., Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell. 89:1997;175-184.
30. Lutjohann J., Spiess A.N., Gercken G. Agonist-stimulated alveolar macrophages: apoptosis and phospholipid signaling. Toxicol. Lett. 97:1998;59-67.
31. Maier L.A., Newman L.S. Beryllium disease. Rom W.N. Environmental and Occupational Medicine. 3rd edition :1998;1021-1035 Lippincott, Philadelphia, PA.
32. McCabe M.J. Jr, Jiang S.A., Orrenius S. Chelation of intracellular zinc triggers apoptosis in mature thymocytes. Lab. Invest. 69:1993;101-110.
33. Messer R.L.W., Lucas L.C. Evaluations of metabolic activities as biocompatibility tools: a study of individual ions' effects on fibroblasts. Dental Materials. 15:1999;1-6.
34. Miller L.J., Marx J. Apoptosis. Science. 281:1998;1301-1326.
35. Misra U.K., Gawdi G., Pizzo S.V., Lewis J.G. Exposure of cultured murine peritoneal macrophages to low concentrations of beryllium induces increases in intracellular calcium concentrations and stimulated DNA synthesis. J. Leukoc. Biol. 65:1999;786-791.
36. Mroz M.M, Kreiss K., Lezotte D.C., Campbell P.A., Newman L.S. Re-examination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease. J. Allergy Clin. Immunol. 88:1991;54-60.
37. Newman L.S. Metals. Harbor P., Schenker M., Balmes J. Occupational and Environmental Respiratory Diseases. 1996;469-513 Mosby, St. Louis, MO.
38. Newman L.S. Significance of the blood beryllium lymphocyte proliferation test (BeLPT). Envrion. Health Perspect. 104:1996;953-956.
39. Newman L.S., Rose C.S., Maier L.A. Sarcoidosis. New Engl. J. Med. 336:1997;1224-1234.
40. Parker V.H., Stevens C. Binding of beryllium to nuclear acidic proteins. Chem.-Biol. Interact. 26:1979;167-177.
41. Price D.J., Joshi J.G. Ferritin. Binding of beryllium and other divalent metal ions. J. Biol. Chem. 258:1983;10873-10880.
42. Rodriguez-Arguelles M.C., Sanchez A., Belicci M.F., Gasparri G.F., Pelizzi C., Pelosi G., Albertini R., Lunghi P., Pinelli S. Transition-metal complexes of isatin-beta-thiosemicarbazone. X-ray crystal structure of two nickel complexes. J. Inorg. Biochem. 73:1999;7-15.
43. Saltini C., Winestock K., Kirby M., Pinkston P., Crystal R.G. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells. New Engl. J. Med. 320:1989;1103-1109.
44. Sarin A., Wu M.L., Henkart P.A. Different interleukin-1β converting enzyme (ICE) family protease requirements for the apoptotic death of T lymphocytes triggered by diverse stimuli. J. Exp. Med. 184:1996;2445-2450.
45. Sarin A., Williams M.S., Alexander-Miller M.A., Berzofsky J.A., Zacharchuk C.M., Henkart P.A. Target cell lysis by CTL granule exocytosis in independent of ICE/Ced-3 family proteases. Immunity. 6:1997;209-215.
46. Satoh K., Kadofuku T., Sakagami H. Copper, but not iron, enhances apoptosis-inducing activity of antioxidants. Anticancer Res. 17:1997;2487-2490.
47. Sawyer R.T. Intravenous zymosan - A challenge induces an alveolar inflammatory response. Inflammation. 17:1993;273-281.
48. Sawyer R.T., Strausbauch P.A., Volkman A. Resident macrophage proliferation in mice depleted of blood monocytes by strontium-89. Lab. Invest. 46:1982;165-170.
49. Sawyer R.T., Hamada H., Kittle L.A., Newman L.S. Beryllium-stimulated tumor necrosis factor-α production by a mouse hybrid macrophage cell line. Toxicology. 143:2000;235-247.
50. Shahar I., Fireman E., Topilsky M., Grief J., Kivity S., Sprier Z., Efraim S.B. Effect of IL-6 on alveolar fibroblast proliferation in interstitial lung diseases. Clin. Immunol. Immunopathol. 79:1996;244-251.
51. Shenker B.J., Datar S., Mansfield K., Shapiro I.M. Induction of apoptosis in human T-cells by organomercuric compounds: a flow cytometric analysis. Toxicol. Appl. Pharm. 64:1997;1335-1341.
52. Shenker B.J., Guo T.L., Shapiro I.M. Low-level methylmercury exposure causes human T-cells to undergo apoptosis: evidence of mitochondrial dysfunction. Environ. Res. 77:1998;149-159.
53. Shimada H., Shiao Y.H., Shibata M., Waalkes M.P. Cadmium suppresses apoptosis induced by chromium. J. Toxicol. Environ. Health. 54:1998;159-168.
54. Thornberry N.A., Lazebnik Y. Caspases: enemies within. Science. 281:1998;1312-1316.
55. Tinkle S.S., Newman L.S. Beryllium-stimulated release of tumor necrosis factor-α, interleukin-6, and their soluble receptors in chronic beryllium disease. Am. J. Respir. Crit. Care Med. 156:1997;1884-1891.
56. Tinkle S.S., Kittle L.A., Schumacher B.A., Newman L.S. Beryllium induces IL-2 and IFN-γ in berylliosis. J. Immunol. 158:1997;518-526.
57. Vourlekis J.S., Sawyer R.T., Newman L.S. Sarcoidosis: developments in etiology, immunology and therapeutics. Adv. Intern. Med. 45:2000;209-257.
58. Witschi H.P., Aldridge W.N. Uptake, distribution and binding of beryllium to organelles of the rat liver cell. Biochem. J. 106:1968;811-820.
59. Wolfe T.J., Ross D., Cohen G.M. A role for metals and free radicals in the induction of apoptosis in thymocytes. FEBS Lett. 352:1994;58-62.
60. Yui S., Mikami M., Tsurumaki K., Yamazaki M. Growth-inhibitory and apoptosis-inducing activities of calprotectin derived from inflammatory exudate cells on normal fibroblasts: regulation by metal ions. J. Leukoc. Biol. 61:1997;50-57.